Pyxis Oncology, Inc. (PYXS)

1.495 +0.04 (+3.10%) USD  |  NASDAQ  |  Feb 24, 16:00
1.495 0.00 (0.00%) After-Hours: 16:48
More

Pyxis Oncology EBITDA Estimates for Current Quarter

EBITDA Estimates for Current Quarter Chart

View EBITDA Estimates for Current Quarter for PYXS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Estimates for Current Quarter Range, Past 5 Years

View EBITDA Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Estimates for Current Quarter Benchmarks

View EBITDA Estimates for Current Quarter Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
Spero Therapeutics, Inc. --
Processa Pharmaceuticals, Inc. --
Alpha Teknova, Inc. Upgrade